Statins are prescribed less often to women with coronary artery disease compared to men. A new study sought to determine why. Find out what factors explain 90% of the disparity.

New Study: Brand Name Drugs Cost an
Excess $73 Billion

Pushing prescribers to use therapeutic substitution is controversial and raises questions about the effect on patient care. Yet, according to a new study, potentially unnecessary use of brand-name medications considerably raises healthcare costs in the United States. Here is more information.

Long-Term Therapy for ‘Low T’ Doesn’t Appear to Increase Prostate Cancer Risk

Androgen-deprivation therapy might be used to treat aggressive prostate cancer. but that doesn’t mean testosterone replacement therapy promotes the disease, according to a new study. In fact, researchers report evidence of lower risk of aggressive prostate cancer with long-term “low T” therapy. Here are the details.